We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Two Proteins Make Reversible Molecular Switch

By Biotechdaily staff writers
Posted on 17 Dec 2004
Nanotechnology researchers have designed a molecular switch by combining two unrelated proteins in a way that causes the response to a specific stimulus by one of the proteins to control the activity of the other.

Investigators at Johns Hopkins University (Baltimore, MD, USA) working with Escherichia coli circularly permuted the gene encoding TEM1 â-lactamase and subsequently randomly inserted it into the gene encoding E coli maltose binding protein. This technique led to the isolation of nearly 27,000 hybrid variations of the two fused proteins. One isolate (RG13) was identified in which its â-lactam hydrolysis activity was inhibited by the absence of maltose but increased 25-fold in its presence. Upon removal of maltose, RG13's catalytic activity returned to the level seen prior to addition of maltose, illustrating that the switching was reversible. These findings were published in the November 2004 issue of Chemistry & Biology.

Senior author Dr. Marc Ostermeier, assistant professor of chemical and biomolecular engineering at Johns Hopkins University, said, "With the new technique, we have produced a molecular switch that is over 10 times more effective. When we introduce this switch into bacteria, it transforms them into a working sensor. We have proven that we can make effective molecular switches. Now, we want to use this idea to create more interesting and more useful devices.”



Related Links:
Johns Hopkins University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
17 Dec 2004  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
17 Dec 2004  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
17 Dec 2004  |   BioResearch